Indication

Vitamin K-dependent coagulation defect

1 clinical trial

2 products

Clinical trial

Post Marketing Observational Study on Safety of BALFAXAR® vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure.

Status: Not yet recruiting, Estimated PCD: 2031-12-31

Product

Product